Literature DB >> 17922014

Network modeling links breast cancer susceptibility and centrosome dysfunction.

Miguel Angel Pujana1, Jing-Dong J Han, Lea M Starita, Kristen N Stevens, Muneesh Tewari, Jin Sook Ahn, Gad Rennert, Víctor Moreno, Tomas Kirchhoff, Bert Gold, Volker Assmann, Wael M Elshamy, Jean-François Rual, Douglas Levine, Laura S Rozek, Rebecca S Gelman, Kristin C Gunsalus, Roger A Greenberg, Bijan Sobhian, Nicolas Bertin, Kavitha Venkatesan, Nono Ayivi-Guedehoussou, Xavier Solé, Pilar Hernández, Conxi Lázaro, Katherine L Nathanson, Barbara L Weber, Michael E Cusick, David E Hill, Kenneth Offit, David M Livingston, Stephen B Gruber, Jeffrey D Parvin, Marc Vidal.   

Abstract

Many cancer-associated genes remain to be identified to clarify the underlying molecular mechanisms of cancer susceptibility and progression. Better understanding is also required of how mutations in cancer genes affect their products in the context of complex cellular networks. Here we have used a network modeling strategy to identify genes potentially associated with higher risk of breast cancer. Starting with four known genes encoding tumor suppressors of breast cancer, we combined gene expression profiling with functional genomic and proteomic (or 'omic') data from various species to generate a network containing 118 genes linked by 866 potential functional associations. This network shows higher connectivity than expected by chance, suggesting that its components function in biologically related pathways. One of the components of the network is HMMR, encoding a centrosome subunit, for which we demonstrate previously unknown functional associations with the breast cancer-associated gene BRCA1. Two case-control studies of incident breast cancer indicate that the HMMR locus is associated with higher risk of breast cancer in humans. Our network modeling strategy should be useful for the discovery of additional cancer-associated genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922014     DOI: 10.1038/ng.2007.2

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  295 in total

1.  Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology.

Authors:  Renu Goel; Babylakshmi Muthusamy; Akhilesh Pandey; T S Keshava Prasad
Journal:  Mol Biotechnol       Date:  2011-05       Impact factor: 2.695

Review 2.  Triple-negative breast cancer: present challenges and new perspectives.

Authors:  Franca Podo; Lutgarde M C Buydens; Hadassa Degani; Riet Hilhorst; Edda Klipp; Ingrid S Gribbestad; Sabine Van Huffel; Hanneke W M van Laarhoven; Jan Luts; Daniel Monleon; Geert J Postma; Nicole Schneiderhan-Marra; Filippo Santoro; Hans Wouters; Hege G Russnes; Therese Sørlie; Elda Tagliabue; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

3.  Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase.

Authors:  Kirsty M Brodie; Beric R Henderson
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 4.  Tools for protein-protein interaction network analysis in cancer research.

Authors:  Rebeca Sanz-Pamplona; Antoni Berenguer; Xavier Sole; David Cordero; Marta Crous-Bou; Jordi Serra-Musach; Elisabet Guinó; Miguel Ángel Pujana; Víctor Moreno
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

5.  Inference of the haplotype effect in a matched case-control study using unphased genotype data.

Authors:  Samiran Sinha; Stephen B Gruber; Bhramar Mukherjee; Gad Rennert
Journal:  Int J Biostat       Date:  2008-05-08       Impact factor: 0.968

Review 6.  Edgotype: a fundamental link between genotype and phenotype.

Authors:  Nidhi Sahni; Song Yi; Quan Zhong; Noor Jailkhani; Benoit Charloteaux; Michael E Cusick; Marc Vidal
Journal:  Curr Opin Genet Dev       Date:  2013-11-26       Impact factor: 5.578

Review 7.  Mechanisms of tumor resistance to EGFR-targeted therapies.

Authors:  Elizabeth A Hopper-Borge; Rochelle E Nasto; Vladimir Ratushny; Louis M Weiner; Erica A Golemis; Igor Astsaturov
Journal:  Expert Opin Ther Targets       Date:  2009-03       Impact factor: 6.902

8.  Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines.

Authors:  Edward H Cho; Rebecca A Whipple; Michael A Matrone; Eric M Balzer; Stuart S Martin
Journal:  Cancer Biol Ther       Date:  2010-01-28       Impact factor: 4.742

9.  Identifying master regulators of cancer and their downstream targets by integrating genomic and epigenomic features.

Authors:  Olivier Gevaert; Sylvia Plevritis
Journal:  Pac Symp Biocomput       Date:  2013

Review 10.  Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy?

Authors:  J Thomas De Ligio; Aneliya Velkova; Diego A R Zorio; Alvaro N A Monteiro
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.